CUL5 and neoplasm: To this end, in the same E.G7-OVA tumor model, we compared the anti-tumor effects of NC, CTLA4 KO, CUL5 KO and CTLA4/CUL5 double KO (DKO) OT-I T cells post adoptive transfer.